BioCentury | Aug 23, 2019
Clinical News

Aug. 22 Clinical Quick Takes: Rituximab biosimilar meets endpoint; plus Aimmune, NKMax, Calibr

...cancer immunotherapy set to enter clinic FDA accepted an IND for immunotherapy CCW702 from the California Institute for Biomedical Research...
...Staff Writers AR201 biosimilar rituximab (ABP 798) MabThera, Rituxan, rituximab (R105, RG105, IDEC-C2B8) Aimmune Therapeutics Inc. Allergan Inc. Amgen Inc. ATGen Co. Ltd. California Institute for Biomedical Research NKMax Scripps...
BioCentury | Jul 25, 2019
Distillery Therapeutics

A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy

...Natl. Acad. Sci. USA ; published online July 08, 2019 doi:10.1073/pnas.1905646116 CONTACT: Peter G. Schultz, California Institute for Biomedical Research...
BioCentury | Mar 22, 2019
Targets & Mechanisms

Deconvoluting translation at Scripps

...Scripps Research . The October 2018 merger formally unites The Scripps Research Institute (TSRI) with California Institute for Biomedical Research...
...San Diego, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Bill & Melinda Gates Foundation, Seattle, Wash. California Institute for Biomedical Research...
...CD26) - Dipeptidyl peptidase-4 FLNA - Filamin A Karen Tkach Tuzman, Associate Editor Bill & Melinda Gates Foundation California Institute for Biomedical Research Genomics...
BioCentury | Mar 19, 2019
Distillery Therapeutics

New brain-penetrating RIPK2 inhibitor prodrug for GBM

...Natl. Acad. Sci. USA ; published online Mar. 4, 2019 doi:10.1073/pnas.1816626116 CONTACT: Peter G. Schultz, California Institute for Biomedical Research...
...email: pmischel@ucsd.edu CONTACT: Luke L. Lairson, The Scripps Research Institute, La Jolla, Calif. email: llairson@scripps.edu Hongjiang Li California Institute for Biomedical Research The...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...Cancer Aug. 2017 Leo Pharma A/S Screening Dermatology April 2017 The Scripps Research Institute / California Institute for Biomedical Research...
BioCentury | Oct 11, 2018
Distillery Therapeutics

Infectious disease

...Natl. Acad. Sci. USA ; published online Oct. 3, 2018 doi:10.1073/pnas.1810137115 CONTACT: Peter G. Schultz, California Institute for Biomedical Research...
...Calif. email: schultz@calibr.org CONTACT: Arnab K. Chatterjee, same affiliation as above email: achatterjee@calibr.org Claire Quang ASP7962 VB-201 Astellas Pharma Inc. California Institute for Biomedical Research Vascular...
BioCentury | Jun 29, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...AbbVie Inc. (NYSE:ABBV) and the California Institute for Biomedical Research (La Jolla, Calif.) partnered to develop universal CAR T therapies...
...see "Calibrating CARS" ). Calibr is an affiliate of Scripps Research Institute (La Jolla, Calif.). California Institute for Biomedical Research...
...Calif. AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Business: Cancer Sandi Wong CAR T cell therapy targeting CD19 AbbVie Inc. California Institute for Biomedical Research The...
BioCentury | Jun 25, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...AbbVie Inc. (NYSE:ABBV) and the California Institute for Biomedical Research (La Jolla, Calif.) partnered to develop universal CAR T therapies...
..."Calibrating CARS" ). Calibr is an affiliate of Scripps Research Institute (La Jolla, Calif.). Sandi Wong AbbVie Inc. California Institute for Biomedical Research Scripps...
BioCentury | May 1, 2018
Distillery Therapeutics

Autoimmune disease

...California Institute for Biomedical Research, La Jolla, Calif. email: schultz@scripps.edu Contact: Weijun Shen, same affiliation as above email: wshen@calibr.org Alicia Parker California Institute for Biomedical Research Glucagon-like...
BioCentury | Mar 22, 2018
Translation in Brief

Mining marine metabolites

...compounds to treat infectious diseases, including tuberculosis and malaria. Sirenas is also partnered with the California Institute for Biomedical Research...
...candidates for immunology, oncology and neglected diseases. Jennie Walters, Staff Writer Bill & Melinda Gates Foundation Bristol-Myers Squibb Co. California Institute for Biomedical Research Sirenas...
Items per page:
1 - 10 of 39
BioCentury | Aug 23, 2019
Clinical News

Aug. 22 Clinical Quick Takes: Rituximab biosimilar meets endpoint; plus Aimmune, NKMax, Calibr

...cancer immunotherapy set to enter clinic FDA accepted an IND for immunotherapy CCW702 from the California Institute for Biomedical Research...
...Staff Writers AR201 biosimilar rituximab (ABP 798) MabThera, Rituxan, rituximab (R105, RG105, IDEC-C2B8) Aimmune Therapeutics Inc. Allergan Inc. Amgen Inc. ATGen Co. Ltd. California Institute for Biomedical Research NKMax Scripps...
BioCentury | Jul 25, 2019
Distillery Therapeutics

A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy

...Natl. Acad. Sci. USA ; published online July 08, 2019 doi:10.1073/pnas.1905646116 CONTACT: Peter G. Schultz, California Institute for Biomedical Research...
BioCentury | Mar 22, 2019
Targets & Mechanisms

Deconvoluting translation at Scripps

...Scripps Research . The October 2018 merger formally unites The Scripps Research Institute (TSRI) with California Institute for Biomedical Research...
...San Diego, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Bill & Melinda Gates Foundation, Seattle, Wash. California Institute for Biomedical Research...
...CD26) - Dipeptidyl peptidase-4 FLNA - Filamin A Karen Tkach Tuzman, Associate Editor Bill & Melinda Gates Foundation California Institute for Biomedical Research Genomics...
BioCentury | Mar 19, 2019
Distillery Therapeutics

New brain-penetrating RIPK2 inhibitor prodrug for GBM

...Natl. Acad. Sci. USA ; published online Mar. 4, 2019 doi:10.1073/pnas.1816626116 CONTACT: Peter G. Schultz, California Institute for Biomedical Research...
...email: pmischel@ucsd.edu CONTACT: Luke L. Lairson, The Scripps Research Institute, La Jolla, Calif. email: llairson@scripps.edu Hongjiang Li California Institute for Biomedical Research The...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...Cancer Aug. 2017 Leo Pharma A/S Screening Dermatology April 2017 The Scripps Research Institute / California Institute for Biomedical Research...
BioCentury | Oct 11, 2018
Distillery Therapeutics

Infectious disease

...Natl. Acad. Sci. USA ; published online Oct. 3, 2018 doi:10.1073/pnas.1810137115 CONTACT: Peter G. Schultz, California Institute for Biomedical Research...
...Calif. email: schultz@calibr.org CONTACT: Arnab K. Chatterjee, same affiliation as above email: achatterjee@calibr.org Claire Quang ASP7962 VB-201 Astellas Pharma Inc. California Institute for Biomedical Research Vascular...
BioCentury | Jun 29, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...AbbVie Inc. (NYSE:ABBV) and the California Institute for Biomedical Research (La Jolla, Calif.) partnered to develop universal CAR T therapies...
...see "Calibrating CARS" ). Calibr is an affiliate of Scripps Research Institute (La Jolla, Calif.). California Institute for Biomedical Research...
...Calif. AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Business: Cancer Sandi Wong CAR T cell therapy targeting CD19 AbbVie Inc. California Institute for Biomedical Research The...
BioCentury | Jun 25, 2018
Company News

AbbVie, Calibr to develop universal CAR T therapies

...AbbVie Inc. (NYSE:ABBV) and the California Institute for Biomedical Research (La Jolla, Calif.) partnered to develop universal CAR T therapies...
..."Calibrating CARS" ). Calibr is an affiliate of Scripps Research Institute (La Jolla, Calif.). Sandi Wong AbbVie Inc. California Institute for Biomedical Research Scripps...
BioCentury | May 1, 2018
Distillery Therapeutics

Autoimmune disease

...California Institute for Biomedical Research, La Jolla, Calif. email: schultz@scripps.edu Contact: Weijun Shen, same affiliation as above email: wshen@calibr.org Alicia Parker California Institute for Biomedical Research Glucagon-like...
BioCentury | Mar 22, 2018
Translation in Brief

Mining marine metabolites

...compounds to treat infectious diseases, including tuberculosis and malaria. Sirenas is also partnered with the California Institute for Biomedical Research...
...candidates for immunology, oncology and neglected diseases. Jennie Walters, Staff Writer Bill & Melinda Gates Foundation Bristol-Myers Squibb Co. California Institute for Biomedical Research Sirenas...
Items per page:
1 - 10 of 39